Holding Company Investment Opportunities in Hyderabad

Holding company structured as a diversified industrial conglomerate, owning and operating multiple cash-flow-positive businesses across infrastructure, manufacturing, healthcare, and sustainability sectors. - Current portfolio includes operating companies across five verticals: infrastructure EPC, precision plastic manufacturing, generic pharmaceuticals, fire protection systems, and organic textile exports. - The infrastructure division is the largest contributor to overall revenue, driven by government EPC contracts. - Infrastructure arm executes large-scale road construction and civil engineering projects for government bodies such as NHAI and private developers. - Manufacturing division supplies high-precision injection-moulded components to Tier-1 automotive and electrical OEMs for critical applications. - Pharmaceutical business operates WHO-GMP certified facilities producing essential generics for hospitals and institutional buyers across therapeutic segments. - Fire protection unit delivers compliance-driven suppression and safety systems for industrial facilities and commercial real estate. - Textile division exports organic, sustainable fabrics to international fashion brands focused on premium eco-conscious apparel. - Portfolio is actively managed through a centralized leadership team, enabling operational oversight, capital allocation, and cross-business efficiencies. - Led by a promoter with strong experience in leveraged buyouts, structured finance, and scaling multi-entity platforms. - Proven acquisition strategy focused on acquiring profitable, undervalued industrial businesses at an average entry multiple of ~4.17x. - Supported by established relationships with NBFCs and structured credit providers, including access to a ₹420 crore senior debt mandate for acquisitions. - The business hires contractual employees. - Revenue is diversified across government contracts, B2B manufacturing supply, institutional pharma sales, industrial safety installations, and export markets. - Holds standard regulatory registrations and certifications, including Certificate of Incorporation (MCA), GST registration, PAN, and sector-specific approvals such as WHO-GMP (pharmaceuticals), along with required environmental and factory compliance licenses across operations. - Currently expanding the platform through targeted acquisitions to further scale EBITDA beyond the current ₹90 crore level and deepen sector presence. - Investment is being raised at the holding company level to fund acquisitions, strengthen integration capabilities, and enhance portfolio scale.

Holding company structured as a diversified industrial conglomerate, owning and operating multiple cash-flow-positive businesses across infrastructure, manufacturing, healthcare, and sustainability sectors. - Current portfolio includes operating companies across five verticals: infrastructure EPC, precision plastic manufacturing, generic pharmaceuticals, fire protection systems, and organic textile exports. - The infrastructure division is the largest contributor to overall revenue, driven by government EPC contracts. - Infrastructure arm executes large-scale road construction and civil engineering projects for government bodies such as NHAI and private developers. - Manufacturing division supplies high-precision injection-moulded components to Tier-1 automotive and electrical OEMs for critical applications. - Pharmaceutical business operates WHO-GMP certified facilities producing essential generics for hospitals and institutional buyers across therapeutic segments. - Fire protection unit delivers compliance-driven suppression and safety systems for industrial facilities and commercial real estate. - Textile division exports organic, sustainable fabrics to international fashion brands focused on premium eco-conscious apparel. - Portfolio is actively managed through a centralized leadership team, enabling operational oversight, capital allocation, and cross-business efficiencies. - Led by a promoter with strong experience in leveraged buyouts, structured finance, and scaling multi-entity platforms. - Proven acquisition strategy focused on acquiring profitable, undervalued industrial businesses at an average entry multiple of ~4.17x. - Supported by established relationships with NBFCs and structured credit providers, including access to a ₹420 crore senior debt mandate for acquisitions. - The business hires contractual employees. - Revenue is diversified across government contracts, B2B manufacturing supply, institutional pharma sales, industrial safety installations, and export markets. - Holds standard regulatory registrations and certifications, including Certificate of Incorporation (MCA), GST registration, PAN, and sector-specific approvals such as WHO-GMP (pharmaceuticals), along with required environmental and factory compliance licenses across operations. - Currently expanding the platform through targeted acquisitions to further scale EBITDA beyond the current ₹90 crore level and deepen sector presence. - Investment is being raised at the holding company level to fund acquisitions, strengthen integration capabilities, and enhance portfolio scale.